The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Multistep carcinogenesis of breast cancer and tumour heterogeneity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Neu-Protein Overexpression in Breast Cancer
van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., & Nusse, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191902 · Cited by 860
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Expression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 661
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
Key, T. J. A., & Pike, M. C. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90173-3 · Cited by 651
Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription
Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994) · Science · doi:10.1126/science.8197458 · Cited by 637
Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast
Ernster, V. L. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530360023033 · Cited by 626
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., & Holt, J. T. (1995) · Nature Genetics · doi:10.1038/ng0495-444 · Cited by 585
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
Dupont, W. D., Parl, F. F., Hartmann, W. H., Brinton, L. A., Winfield, A. C., Worrell, J. A., Schuyler, P. A., & Plummer, W. D. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i · Cited by 528
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
Xiong, Y., Zhang, H., & Beach, D. (1993) · Genes & Development · doi:10.1101/gad.7.8.1572 · Cited by 507
A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer
London, S. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480070057030 · Cited by 504
Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., & Nakamura, Y. (1990) · PubMed · Cited by 501
Allred, D. C., Clark, G. M., Tandon, A. K., Molina, R., Tormey, D. C., Osborne, C. K., Gilchrist, K. W., Mansour, E. G., Abeloff, M., & Eudey, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.599 · Cited by 456
Histological Typing of Breast Tumors
World Health Organization, G., Azzopardi, J. G., Chepick, O. F., Hartman, W. H., Jafarey, N. A., Llombard-Bosch, A., Ozzello, L., Rilke, F., Sasano, N., Sobin, L. H., et al. (1982) · Tumori Journal · doi:10.1177/030089168206800301 · Cited by 444
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J., & Baylin, S. B. (1995) · Nature Medicine · doi:10.1038/nm0695-570 · Cited by 421
Germ-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340302 · Cited by 385
Genetic alterations in the adenoma–carcinoma sequence
Cho, K. R., & Vogelstein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p · Cited by 381
Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G.-Y., Abel, K. J., Weber, B. L., & Chodosh, L. A. (1995) · Nature Genetics · doi:10.1038/ng0995-17 · Cited by 336
Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., & Steeg, P. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1257 · Cited by 335
Schuuring, E., Verhoeven, E., Mooi, W. J., & Michalides, R. J. A. M. (1992) · PubMed · Cited by 317
RISK FACTORS FOR BREAST CANCER
Helmrich, S. P., Shapiro, S., Rosenberg, L. A., Kaufman, D. W., Slone, D., Bain, C. J., Miettinen, O. S., Stolley, P. D., Rosenshein, N. B., KNAPP, R. C., et al. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113513 · Cited by 316
Aberrant Subcellular Localization of BRCA1 in Breast Cancer
Chen, Y., Chen, C.-F., Riley, D. J., Allred, D. C., Chen, P.-L., Von Hoff, D., Osborne, C. K., & Lee, W.-H. (1995) · Science · doi:10.1126/science.270.5237.789 · Cited by 309
Ferguson, A. T., Lapidus, R. G., Baylin, S. B., & Davidson, N. E. (1995) · PubMed · Cited by 297
An Association between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus
Krontiris, T. G., Devlin, B., Karp, D. D., Robert, N. J., & Risch, N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290801 · Cited by 287
BRCA1 Mutations in a Population-Based Sample of Young Women with Breast Cancer
Langston, A. A., Malone, K. E., Thompson, J. D., Daling, J. R., & Ostrander, E. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340301 · Cited by 286
The genetics of breast and ovarian cancer
Ford, D., & Easton, D. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.417 · Cited by 264
Prognostic Factors and Therapeutic Decisions in Axillary Node-Negative Breast Cancer
Elledge, R. M., & McGuire, W. L. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001221 · Cited by 257
Packham, G., & Cleveland, J. L. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)00015-t · Cited by 245
p53 mutations in breast cancer.
Coles, C., Condie, A., Chetty, U., Steel, C., Evans, H. J., & Prosser, J. (1992) · PubMed · Cited by 241
ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS
Mackay, J., Elder, P., Steel, C. M., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90584-3 · Cited by 236
Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation.
Holland, R., & Hendriks, J. H. C. L. (1994) · PubMed · Cited by 236
Somatic genetic changes in human breast cancer
Devilee, P. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90009-4 · Cited by 209
Lakhani, S. R., Collins, N., Stratton, M. R., & Sloane, J. P. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.611 · Cited by 204
Berns, E., Klijn, J. G. M., van Putten, W. L., van Staveren, I. L., Portengen, H., & Foekens, J. A. (1992) · PubMed · Cited by 201
Futreal, P. A., Söderkvist, P., Marks, J. R., Iglehart, J. D., Cochran, C., Barrett, J. C., & Wiseman, R. W. (1992) · PubMed · Cited by 200
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B., Mackenzie, I. M., Cranston, G., Mackay, J., Macdonald, M., Steel, C. M., Thompson, A. M., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)93236-i · Cited by 200
Prognostic factors in early breast carcinoma
Mansour, E. G., Ravdin, P. M., & Dressier, L. (1994) · Cancer · doi:10.1002/cncr.2820741326 · Cited by 199
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.
Liu, E., Thor, A. D., He, M., Barcos, M. P., Ljung, B., & Benz, C. C. (1992) · PubMed · Cited by 193
c-erbB-2 expression in benign and malignant breast disease
Gusterson, B., Machin, L., Gullick, W., Gibbs, N., Powles, T., Elliott, C., Ashley, S., Monaghan, P., & Harrison, S. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.239 · Cited by 190
Self-citationInvasive breast cancer risk in women with sclerosing adenosis
Jensen, R. A., Page, D. L., Dupont, W. D., & Rogers, L. W. (1989) · Cancer · Cited by 184
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.
Eisinger, F., Stoppa‐Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincent‐Salomon, A., Jacquemier, J. D., Birnbaum, D., & Sobol, H. (1996) · PubMed · Cited by 171
Radford, D. M., Fair, K., Phillips, N. J., Ritter, J. H., Steinbrueck, T., Holt, M. S., & Donis-Keller, H. (1995) · PubMed · Cited by 159
Changing trends: An overview of breast cancer incidence and mortality
Garfinkel, L., Boring, C. C., & Heath, C. W. (1994) · Cancer · doi:10.1002/cncr.2820741304 · Cited by 158
Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Watanabe, S., Terada, M., & Yamamoto, H. (1990) · Cancer · Cited by 151
Thompson, A. M., Anderson, T. J., Condie, A., Prosser, J., Chetty, U., Carter, D. C., Evans, H. J., & Steel, C. M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500405 · Cited by 147
(1990) · PubMed · Cited by 142
Aldaz, C. M., Chen, T.-X., Şahin, A. A., Cunningham, J. G., & Bondy, M. L. (1995) · PubMed · Cited by 137
McCann, A. H., Kirley, A., Carney, D. N., Corbally, N., Magee, H. M., Keating, G., & Dervan, P. A. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.189 · Cited by 125
Zhuang, Z., Merino, M. J., Chuaqui, R., Liotta, L. A., & Emmert-Buck, M. R. (1995) · PubMed · Cited by 125
Fujimoto, N., & Katzenellenbogen, B. S. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.3.7517003 · Cited by 124
Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng, G., Chen, L. C., Schott, D. R., Thor, A. D., Bhargava, V., Ljung, B., Chew, K., & Smith, H. S. (1994) · PubMed · Cited by 124
Pavelić, Z. P., Pavelić, L., Lower, E. E., Gapany, M., Gapany, S. R., Barker, E. A., & Preisler, H. D. (1992) · PubMed · Cited by 124
Beckmann, M., Picard, F., An, H., van Roeyen, C. R. C., Dominik, S., Mosny, D., Schnürch, H.-G., Bender, H., & Niederacher, D. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.234 · Cited by 119
Self-citationMolecular genetic studies of early breast cancer evolution
O'Connell, P., Pekkel, V., Fuqua, S. A. W., Osborne, C. K., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666201 · Cited by 118
Tumourigenesis associated with the p53 tumour suppressor gene
Chang, F., Syrjänen, S., Tervahauta, A. I., & Syrjänen, K. J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.404 · Cited by 117
Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer
Fantl, V., Richards, M. A., Smith, D., Lammie, G. A., Johnstone, G., Allen, D., Gregory, W. M., Peters, G., Dickson, C., & Barnes, D. M. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90009-i · Cited by 114
The D-type cyclins and their role in tumorigenesis
Peters, G. G. (1994) · Journal of Cell Science · doi:10.1242/jcs.1994.supplement_18.13 · Cited by 112
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
Xu, L., Sgroi, D. C., Sterner, C. J., Beauchamp, R. L., Pinney, D., Keel, S. B., Ueki, K., Rutter, J. L., Buckler, A., & Louis, D. N. (1994) · PubMed · Cited by 108
Tsuda, H., Callen, D. F., Fukutomi, T., Nakamura, Y., & Hirohashi, S. (1994) · PubMed · Cited by 108
Antiestrogens: Mechanisms and actions in target cells
Katzenellenbogen, B. S., Montano, M. M., Goff, P. L., Schodin, D. J., Kraus, W. L., Bhardwaj, B., & Fujimoto, N. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00084-d · Cited by 107
Andersen, T. I., Gaustad, A., Børresen‐Dale, A., Farrants, G. W., Nesland, J. M., Ottestad, L., & Tveit, K. M. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870040203 · Cited by 104
c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
Somerville, J. E., Clarke, L., & Biggart, J. D. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.1.16 · Cited by 101
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13
Cleton-Jansen, A. M., Collins, N., Lakhani, S. R., Weissenbach, J., Devilee, P., Cornelisse, C., & Stratton, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.493 · Cited by 98
Genetic epidemiology of breast cancer
Thompson, D. W. (1994) · Cancer · doi:10.1002/cncr.2820741312 · Cited by 94
Watson, P. H., Safneck, J. R., Le, K., Dubik, D., & Shiu, R. P. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.902 · Cited by 85
Cropp, C. S., Champème, M. H., Lidereau, R., & Callahan, R. (1993) · PubMed · Cited by 74
Kreipe, H. H., Feist, H., Fischer, L., Felgner, J., Heidorn, K., Mettler, L., & Parwaresch, R. M. (1993) · PubMed · Cited by 73
Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes
Demetrick, D. J., Zhang, H., & Beach, D. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133669 · Cited by 52
Murphy, D. S., McHardy, P., COUTTS, J. C., Mallon, E., George, W. D., Kaye, S. B., Brown, R. E., & Keith, W. N. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640106 · Cited by 51
Black, D. M. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00386-j · Cited by 47
Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
Meyers, S., O'Brien, M. T., Smith, T., & Dudley, J. P. (1990) · PubMed · Cited by 47
Loss of heterozygosity of the oestrogen receptor gene in breast cancer
Iwase, H., Greenman, J., Barnes, D. M., Bobrow, L. G., Hodgson, S. V., & Mathew, C. G. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.91 · Cited by 42
Taverna, D., Antoniotti, S., Maggiora, P., Dati, C., Bortoli, M. D., & Hynes, N. E. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560411 · Cited by 39
Prenatal factors may influence predisposition to breast cancer
Anbazhagan, R., & Gusterson, B. A. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80006-1 · Cited by 38
Self-citationMerlo, G. R., Venesio, T., Bernardi, A., Canale, L., Gaglia, P., Lauro, D., Cappa, A. P. M., Callahan, R., & Liscia, D. S. (1992) · PubMed Central · Cited by 37
Lizard‐Nacol, S., Lidereau, R., Collin, F., Arnal, M., Hahnel, L., Roignot, P., Cuisenier, J., & Guerrin, J. (1995) · PubMed · Cited by 35
Estrogen Use and Cancer Risk: A Review
LUPULESCU, A. P. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211234 · Cited by 32
An, H., Niederacher, D., Beckmann, M. W., Göhring, U.-J., Scharl, A. J., Picard, F., van Roeyen, C. R. C., Schnürch, H.-G., & Bender, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640502 · Cited by 30
Self-citationMolecular biology of breast carcinoma
El‐Ashry, D., & Lippman, M. E. (1994) · World Journal of Surgery · doi:10.1007/bf00348187 · Cited by 24
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Abd El‐Rehim, D. M., Ball, G., Pinder, S. E., Rakha, E., Paish, C., Robertson, J. F. R., Macmillan, D., Blamey, R. W., & Ellis, I. O. (2005) · International Journal of Cancer · doi:10.1002/ijc.21004 · Cited by 606
Buerger, H., Otterbach, F., Simon, R., Poremba, C., Diallo, R., Decker, T., Riethdorf, L., Brinkschmidt, C., Dockhorn-Dworniczak, B., & Boecker, W. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199903)187:4<396::aid-path286>3.0.co;2-l · Cited by 328
Zhou, X., Tan, M., Stone Hawthorne, V., Klos, K. S., Lan, K.-H., Yang, Y., Yang, W., Smith, T. L., Shi, D., & Yu, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0112 · Cited by 312
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0180 · Cited by 287
Metadata
- Authors
- Beckmann, M. W., Niederacher, D., Schnürch, H.-G., Gusterson, B. A., & Bender, H. G.
- Venue
- Journal of Molecular Medicine
- Published
- 1997-05-16
- Volume
- 75
- Issue
- 6
- Pages
- 429-439
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2115408783
- Cited by
- 299
- References
- 91
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.